Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -12,648 | 0 | 0 | -9,666 |
| Depreciation Amortization | N/A | 198 | 0 | 0 | 30 |
| Other Working Capital | N/A | -420 | 0 | 0 | 640 |
| Other Operating Activity | 0 | 1,412 | 0 | 0 | 1,522 |
| Operating Cash Flow | $N/A | $-11,458 | $0 | $0 | $-7,474 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -394 | 0 | 0 | -56 |
| Investing Cash Flow | $N/A | $-394 | $0 | $0 | $-56 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 36,963 | 0 | 0 | -583 |
| Financing Cash Flow | $N/A | $36,963 | $0 | $0 | $-583 |
| Exchange Rate Effect | N/A | -366 | 0 | 0 | -161 |
| Beginning Cash Position | N/A | 17,344 | 0 | 0 | 25,618 |
| End Cash Position | N/A | 42,089 | 0 | 0 | 17,344 |
| Net Cash Flow | $N/A | $24,745 | $0 | $0 | $-8,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -11,458 | 0 | 0 | -7,474 |
| Free Cash Flow | 0 | -11,458 | 0 | 0 | -7,474 |